Page last updated: 2024-08-25

zoledronic acid and Hyperparathyroidism

zoledronic acid has been researched along with Hyperparathyroidism in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Fardeen, KM; Kotecha, J; Mirzazadeh, M1
Bae, WK; Chung, IJ1
Sayin, M; Yazici, G1
Asuncion, F; Chiusaroli, R; Khatri, R; Kostenuik, P; Ohishi, M; Ominsky, M; Schipani, E; Thomas, C1
Chen, J; Li, N; Ling, R; Lv, Y; Wang, H; Wang, L; Wang, T; Yao, Q; Yi, J; Yuan, S; Zhang, J1
Anastasilakis, AD; Polyzos, SA; Terpos, E1
Civantos Modino, S; Díaz Guardiola, P; Guijarro de Armas, MG; Montaño Martínez, JM; Pavón de Paz, I; Zubieta Tabernero, J1
Barone, A; Foppiani, L; Palummeri, E; Prete, C; Senesi, B; Trasciatti, S; Veneziano, M1

Reviews

1 review(s) available for zoledronic acid and Hyperparathyroidism

ArticleYear
Primary hyperparathyroidism and neuropsychiatric alterations in a nonagenarian woman.
    Aging clinical and experimental research, 2005, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Diseases, Metabolic; Cognition Disorders; Diphosphonates; Disease Progression; Diuretics; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Nervous System Diseases; Sodium Chloride; Treatment Outcome; Zoledronic Acid

2005

Other Studies

7 other study(ies) available for zoledronic acid and Hyperparathyroidism

ArticleYear
Hyperparathyroidism Following Denosumab and Zoledronate Therapy in a Secondary Care Setting.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2023, 03-01, Volume: 29, Issue:2

    Topics: Bone Density; Bone Density Conservation Agents; Denosumab; Humans; Hyperparathyroidism; Secondary Care; Zoledronic Acid

2023
Full-blown hyperparathyroidism.
    The Korean journal of internal medicine, 2018, Volume: 33, Issue:6

    Topics: Adult; Biomarkers; Bone Density Conservation Agents; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hyperparathyroidism; Infusions, Intravenous; Male; Parathyroid Hormone; Saline Solution; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid

2018
Hyperparathyroidism secondary to zoledronic acid infusion: case report.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:5

    Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hyperparathyroidism; Imidazoles; Lymphoma; Middle Aged; Stomach Neoplasms; Zoledronic Acid

2009
Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.
    The American journal of pathology, 2009, Volume: 174, Issue:6

    Topics: Alendronate; Animals; Biomechanical Phenomena; Bone and Bones; Bone Resorption; Diphosphonates; Disease Models, Animal; Humans; Hyperparathyroidism; Imidazoles; Immunohistochemistry; Male; Mice; Mice, Transgenic; Osteoclasts; Osteoprotegerin; Porosity; Primary Myelofibrosis; Receptor, Parathyroid Hormone, Type 1; Tomography, X-Ray Computed; Zoledronic Acid

2009
Zoledronic acid may be a treatment option for hyperparathyroidism.
    Medical hypotheses, 2009, Volume: 73, Issue:3

    Topics: Bone Density Conservation Agents; Diphosphonates; Hyperparathyroidism; Imidazoles; Models, Biological; Thyroid Gland; Zoledronic Acid

2009
Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:10

    Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Hyperparathyroidism; Imidazoles; Infusions, Intravenous; Stomach Neoplasms; Zoledronic Acid

2009
[Primary hyperparathyroidism in a patient with Paget's bone disease].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:4

    Topics: Adenoma; Aged; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Osteitis Deformans; Osteoporosis; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Zoledronic Acid

2010